High-field neuroimaging in Parkinson's disease

High Field Brain MRI: Use in Clinical Practice

Volumn , Issue , 2006, Pages 194-200

  Peran P ^a   Luccichenti, G ^a   Cherubini, A ^a   Hagberg, G E ^a   Sabatini, U ^a  

^a IRCCS FONDAZIONE SANTA LUCIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84885798955     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/3-540-31776-7_16     Document Type: Chapter

References (32)

1. Adachi M, Hosoya T, Haku T, et al. (1999) Evaluation of the substantia nigra in patients with Parkinsonian syndrome accomplished using multishot diffusion-weighted MR imaging. Am J Neuroradiol 20:1500-1506
2. Alexander GE, DeLong MR, Strick PL (1986) Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu Rev Neurosci 9:357-381
3. Antonini A, Leenders KL, Meier D, et al. (1993) T2 relaxation time in patients with Parkinson's disease. Neurology 43:697-700
4. Bartzokis G, Cummings JL,Markham CH, et al. (1999) MRI evaluation of brain iron in earlier- and later-onset Parkinson's disease and normal subjects. Magn Reson Imaging 17:213-222
5. Brooks DJ (2004) Neuroimaging in Parkinson's disease. NeuroRx 1:243-254
6. Burton EJ, McKeith IG, Burn DJ, et al. (2004) Cerebral atrophy in Parkinson's disease with and without dementia: a comparison with Alzheimer's disease, dementia with Lewy bodies and controls. Brain 127:791-800
7. Eckert T, SailerM, Kaufmann J, et al. (2004)Differentiation of idiopathic Parkinson's disease, multiple system atrophy, progressive supranuclear palsy, and healthy controls using magnetization transfer imaging. Neuroimage 21:229-235
8. GrahamJM,PaleyMN,GrunewaldRA, et al. (2000)Brain iron deposition in Parkinson's disease imaged using the PRIME magnetic resonance sequence. Brain 123(12): 2423-2431
9. Haslinger B, Erhard P, Kampfe N, et al. (2001) Event-related functional magnetic resonance imaging in Parkinson's disease before and after levodopa. Brain 124:558-570
10. HuMT,White SJ,HerlihyAH, et al. (2001) Acomparison of (18)F-dopa PET and inversion recovery MRI in the diagnosis of Parkinson's disease. Neurology 56:1195-1200
11. Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55:181-184
12. Hutchinson M, Raff U (2000) Structural changes of the substantia nigra in Parkinson's disease as revealed by MR imaging. Am J Neuroradiol 21:697-701
13. HutchinsonM, Raff U, Lebedev S (2003)MRI correlates of pathology in parkinsonism: segmented inversion recovery ratio imaging (SIRRIM). Neuroimage 20:1899-1902
14. Jahanshahi M, Jenkins IH, Brown RG, et al. (1995) Self-initiated versus externally triggered movements. I. An investigation using measurement of regional cerebral blood flow with PET and movement-related potentials in normal and Parkinson's disease subjects. Brain 118(4):913-933
15. Kosta P, Argyropoulou MI, Markoula S, Konitsiotis S (2005) MRI evaluation of the basal ganglia size and iron content in patients with Parkinson's disease. J Neurol (in press)
16. Lehericy S, Ducros M, Van de Moortele PF, et al. (2004) Diffusion tensor fiber tracking shows distinct corticostriatal circuits in humans. Ann Neurol 55:522-529
17. Oikawa H, Sasaki M, Tamakawa Y, et al. (2002) The substantia nigra in Parkinson disease: proton density-weighted spin-echo and fast short inversion time inversion-recovery MR findings. Am J Neuroradiol 23: 1747-1756
18. Playford ED, Jenkins IH, Passingham RE, et al. (1992) DJ impairedmesial frontal and putamen activation in Parkinson's disease: a positron emission tomography study. Ann Neurol 32:151-161
19. Rademacher J, Engelbrecht V, Burgel U, et al. (1999) Measuring in vivo myelination of human white matter fiber tracts with magnetization transfer MR. Neuroimage 9: 393-406
20. Rascol O, SabatiniU, Chollet F, et al. (1992) Supplementary and primary sensory motor area activity in Parkinson's disease. Regional cerebral blood flow changes during finger movements and effects of apomorphine. Arch Neurol 49:144-148
21. Rascol O, Sabatini U, Chollet F, et al. (1994) Normal activation of the supplementarymotor area in patients with Parkinson's disease undergoing long-term treatment with levodopa. J Neurol Neurosurg Psychiatry 57:567-571
22. Ryvlin P, Broussolle E, Piollet H, et al. (1995)Magnetic resonance imaging evidence of decreased putamenal iron content in idiopathic Parkinson's disease. Arch Neurol 52: 583-588
23. Sabatini U, Boulanouar K, Fabre N, et al. (2000) Cortical motor reorganization in akinetic patients with Parkinson's disease: a functional MRI study. Brain 123(2):394-403
24. Samuel M, Ceballos-Baumann AO, Boecker H, Brooks DJ (2001) Motor imagery in normal subjects and Parkinson's disease patients: anH2 15O PET study. Neuroreport 12:821-828
25. Schocke MF, Seppi K, Esterhammer R, et al. (2002) Diffusion-weighted MRI differentiates the Parkinson variant of multiple system atrophy from PD. Neurology 58:575-580
26. SchockeMF, Seppi K, Esterhammer R, et al. (2004) Trace of diffusion tensor differentiates the Parkinson variant of multiple system atrophy and Parkinson's disease. Neuroimage 21:1443-1451
27. Seppi K, SchockeMF,Donnemiller E, et al. (2004) Comparison of diffusion-weighted imaging and [123I]IBZM-SPECT for the differentiation of patients with the Parkinson variant of multiple system atrophy from those with Parkinson's disease. Mov Disord 19:1438-1445
28. Seppi K, Schocke MF, Esterhammer R, et al. (2003) Diffusion-weighted imaging discriminates progressive supranuclear palsy fromPD, but not from the Parkinson variant of multiple system atrophy. Neurology 60:922-927
29. Summerfield C, Junque C, Tolosa E, et al. (2005) Structural brain changes in Parkinson disease with dementia: a voxel-based morphometry study. Arch Neurol 62:281-285
30. Ye FQ, Allen PS,Martin WR(1996) Basal ganglia iron content in Parkinson's disease measured with magnetic resonance. Mov Disord 11:243-249
31. Youdim MB, Riederer P (2004) A review about brain iron in normal and pathological conditions. In: Encyclopedia of neuroscience. Elsevier, Amsterdam
32. Zecca L, Youdim MB, Riederer P, et al. (2004) Iron, brain ageing and neurodegenerative disorders.Nat RevNeurosci 5:863-873